Combinatorial therapy with an acetylcholinesterase inhibitor and (3aR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3,-b]indol-5-yl phenylcarbamate

摘要

The present invention relates to an improved method of treating, reducing or delaying cognitive impairments associated with the beta-amyloid peptide, either in combination with treatment by cholinomimetic replacement therapy or as a prophylactic treatment.